drugset / Trial / NCT01442363

A Safety and Efficacy Study of BLI-1300 Ointment in Symptomatic Perianal Crohn's Disease

NCT01442363 ↗

Phase 2 Terminated 4 enrolled Braintree Laboratories
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This randomized, placebo-controlled, parallel, multi-center, double-blind pilot study is designed to determine the effects of BLI-1300 ointment on perianal pain associated with active Perianal Crohn's Disease (PCD).

Timeline

Start
2011-11
Primary completion
2012-10
Completion
2012-10

Outcome

Outcome not reported

Stopped (Enrollment): “Lack of recruitment, discontinuation of program”

Drugs

EvaluationDrugModalityDoseRoute
Subject BLI-1300 Unknown 10 % Topical
Subject BLI-1300 Unknown 20 % Topical